These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7405010)

  • 1. Influenza vaccination by nasal route in a semi-closed community.
    Steiner N; Petrescu A; Teodosiu O; Mihail A; Mihăilescu M; Steiner G; Berca C; Călina A; Soare C
    Virologie; 1980; 31(2):117-20. PubMed ID: 7405010
    [No Abstract]   [Full Text] [Related]  

  • 2. [Secretory and serum response after intranasal influenza vaccination with A/Victoria attenuated live virus].
    Crifò S; Filiaci F; Pelosio A; Rocchi G
    Boll Soc Ital Biol Sper; 1978 Jun; 54(11):1021-6. PubMed ID: 743410
    [No Abstract]   [Full Text] [Related]  

  • 3. Experience of nasal application of inactivated influenza vaccine.
    Fukumi H
    Dev Biol Stand; 1976; 33():155-61. PubMed ID: 782963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials with intranasally administered WRL 105 strain live influenza vaccine in volunteers.
    Freestone DS
    Dev Biol Stand; 1976; 33():207-12. PubMed ID: 782971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and protective efficacy of influenza vaccination.
    Hannoun C; Megas F; Piercy J
    Virus Res; 2004 Jul; 103(1-2):133-8. PubMed ID: 15163501
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine.
    Greenbaum E; Furst A; Kiderman A; Stewart B; Levy R; Schlesinger M; Morag A; Zakay-Rones Z
    J Med Virol; 2001 Sep; 65(1):178-84. PubMed ID: 11505461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complex studies of virology, microbiology, biochemistry and epidemiology in the adults of a semi-closed community vaccinated against influenza with the inactivated NIVGRIP vaccine intranasally].
    Steiner N; Ionită I; Zaharia CN; Petrescu A; Ciocîrlie I; Stafie D; Dicu A; Stanciu A; Muşat G
    Rev Roum Virol; 1992; 43(1-2):47-58. PubMed ID: 1283825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Criteria in the evaluation of live intranasal influenza virus vaccines.
    Zygraich N
    Dev Biol Stand; 1976; 33():141-50. PubMed ID: 782962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The experience of the "Stefan S. Nicolau" Institue of Virology in the preparation of administration of inactivated influenza vaccines applicable by nasal or oral route.
    Petrescu A; Cajal N; Broniţki A; Mihail A; Teodosiu O; Popescu G; Isaia G; Popescu A
    Virologie; 1977; 28(3):213-7. PubMed ID: 898654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary results of oral influenza vaccination with live attenuated viruses.
    DeBarbieri A; Crovari P; Cuneo-Crovari P; Badolati G; Giacometti G
    Dev Biol Stand; 1976; 33():213-9. PubMed ID: 782972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influenza live attenuated intra-nasal vaccines].
    Weil-Olivier C
    Arch Pediatr; 2010 Jun; 17(6):904-5. PubMed ID: 20654953
    [No Abstract]   [Full Text] [Related]  

  • 12. A clinical trial of WRL 105 strain live attenuated influenza vaccine comparing four methods of intranasal vaccination.
    White WG; Freestone DS; Bowker CH; Barnes GM; Letley E; Ferris RD
    Dev Biol Stand; 1976; 33():202-6. PubMed ID: 782970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination.
    Muhamed G; Greenbaum E; Zakay-Rones Z
    Isr Med Assoc J; 2006 Mar; 8(3):155-8. PubMed ID: 16599048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients.
    Vogtländer NP; Brown A; Valentijn RM; Rimmelzwaan GF; Osterhaus AD
    Vaccine; 2004 Jun; 22(17-18):2199-201. PubMed ID: 15149777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preventive influenza vaccination].
    Glathe H
    Z Arztl Fortbild (Jena); 1990; 84(8):377-80. PubMed ID: 2378120
    [No Abstract]   [Full Text] [Related]  

  • 16. Bivalent influenza vaccination with inactivated vaccines administered by nasal or oral route.
    Petrescu A; Mihail A; Popescu A; Cojiţă M; Sternberg I; Steiner N; Hondor C
    Virologie; 1976; 27(1):41-5. PubMed ID: 941402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine.
    Greenbaum E; Engelhard D; Levy R; Schlezinger M; Morag A; Zakay-Rones Z
    Vaccine; 2004 Jun; 22(20):2566-77. PubMed ID: 15193382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological evaluation of the protection conferred by the Nivgrip vaccine against influenza caused by the A(H1N1) virus.
    Teodorovici G; Ivan A; Petrescu A; Mihail A; Cajal N
    Virologie; 1982; 33(4):279-82. PubMed ID: 7164342
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of live attenuated influenza vaccine ts-1(E) in man.
    Gwaltney JM
    Dev Biol Stand; 1976; 33():178-83. PubMed ID: 782966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of neutralizing secretory influenza antibodies after nasal administration of the NIVGRIP trivalent influenza vaccine.
    Petrescu A; Steiner N; Trăilescu G; Teodosiu O; Mihăilescu M; Berca C
    Virologie; 1985; 36(3):187-94. PubMed ID: 4071977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.